Hormone-receptor status and likelihood of predicting pathological complete response (pCR) in the NOAH trial of neoadjuvant trastuzumab in patients (pts) with HER2-positive locally advanced breast cancer (LABC)

✍ Scribed by W. Eiermann; J. Baselga; V. Semiglazov; M. Byakhov; E. Ciruelos; B. Ojeda; A. Feyereislova; M. Zambetti; P. Valagussa; L. Gianni

• Book ID: 119598038
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 63 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)70544-5